Zdrowie i gospodarka · 21/07/2023
Prospective Grant of an Exclusive Patent License: Development and Commercialization of Caspase Inhibitors
The National Center for Advancing Translational Sciences is contemplating the grant of an Exclusive Patent License to Elgia Therapeutics Inc. for the development and commercialization of caspase inhibitors.